# Maxlinear, Inc: overview

MXL · Nasdaq · CIK 1288469 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mxl.md) · [Financials](/companies/mxl/financials.md) · [Filings](/companies/mxl/filings.md) · [Insiders](/companies/mxl/insiders.md)

Latest reported revenue: [$218.1m](/filings/0001288469-26-000061.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 22, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001288469-26-000061).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [92.2 d](/filings/0001288469-26-000011.md) | [95.9](/filings/0001288469-26-000029.md) | [109](/filings/0001288469-26-000051.md) | [126](/filings/0001288469-26-000061.md) | [136 d](/filings/0001288469-26-000011.md) | [137](/filings/0001288469-26-000029.md) | [169](/filings/0001288469-26-000051.md) | [218](/filings/0001288469-26-000061.md) |
| Gross margin | % | [55.6% d](/filings/0001288469-26-000011.md) | [56.1%](/filings/0001288469-26-000029.md) | [56.5%](/filings/0001288469-26-000051.md) | [56.9%](/filings/0001288469-26-000061.md) | [57.6% d](/filings/0001288469-26-000011.md) | [57.5%](/filings/0001288469-26-000029.md) | [57.8%](/filings/0001288469-26-000051.md) | [58.7%](/filings/0001288469-26-000061.md) |
| Operating margin | % | [(44.7%) d](/filings/0001288469-26-000011.md) | [(48.0%)](/filings/0001288469-26-000029.md) | [(22.6%)](/filings/0001288469-26-000051.md) | [(32.7%)](/filings/0001288469-26-000061.md) | [(10.9%) d](/filings/0001288469-26-000011.md) | [(12.5%)](/filings/0001288469-26-000029.md) | [(2.5%)](/filings/0001288469-26-000051.md) | [13.9%](/filings/0001288469-26-000061.md) |
| Net margin | % | [(62.8%) d](/filings/0001288469-26-000011.md) | [(51.8%)](/filings/0001288469-26-000061.md) | [(24.4%)](/filings/0001288469-26-000061.md) | [(36.0%)](/filings/0001288469-26-000061.md) | [(10.9%) d](/filings/0001288469-26-000011.md) | [(32.9%)](/filings/0001288469-26-000061.md) | [1.0%](/filings/0001288469-26-000061.md) | [13.3%](/filings/0001288469-26-000061.md) |
| Diluted EPS | $ per share | not reported | [(0.58)](/filings/0001288469-26-000029.md) | [(0.31)](/filings/0001288469-26-000051.md) | [(0.52)](/filings/0001288469-26-000061.md) | not reported | [(0.52)](/filings/0001288469-26-000029.md) | [0.02](/filings/0001288469-26-000051.md) | [0.30](/filings/0001288469-26-000061.md) |
| Free cash flow | $m | [(30.0) d](/filings/0001288469-26-000011.md) | [(13.4)](/filings/0001288469-26-000029.md) | [9.3 d](/filings/0001288469-26-000051.md) | [4.4 d](/filings/0001288469-26-000061.md) | [6.7 d](/filings/0001288469-26-000011.md) | [(10.3)](/filings/0001288469-26-000029.md) | [2.5 d](/filings/0001288469-26-000051.md) | [(19.5) d](/filings/0001288469-26-000061.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [892](/filings/0001288469-24-000015.md) | [1,120](/filings/0001288469-25-000008.md) | [693](/filings/0001288469-26-000011.md) | [361](/filings/0001288469-26-000011.md) | [468](/filings/0001288469-26-000011.md) |
| Gross margin | % | [55.6%](/filings/0001288469-24-000015.md) | [58.0%](/filings/0001288469-25-000008.md) | [55.6%](/filings/0001288469-26-000011.md) | [54.0%](/filings/0001288469-26-000011.md) | [56.8%](/filings/0001288469-26-000011.md) |
| Operating margin | % | [7.3%](/filings/0001288469-24-000015.md) | [16.1%](/filings/0001288469-25-000008.md) | [(5.5%)](/filings/0001288469-26-000011.md) | [(62.0%)](/filings/0001288469-26-000011.md) | [(27.1%)](/filings/0001288469-26-000011.md) |
| Net margin | % | [4.7%](/filings/0001288469-24-000015.md) | [11.2%](/filings/0001288469-25-000008.md) | [(10.6%)](/filings/0001288469-26-000011.md) | [(68.0%)](/filings/0001288469-26-000011.md) | [(29.2%)](/filings/0001288469-26-000011.md) |
| Diluted EPS | $ per share | [0.53](/filings/0001288469-24-000015.md) | [1.55](/filings/0001288469-25-000008.md) | [(0.91)](/filings/0001288469-26-000011.md) | [(2.93)](/filings/0001288469-26-000011.md) | [(1.58)](/filings/0001288469-26-000011.md) |
| Free cash flow | $m | [129](/filings/0001288469-24-000015.md) | [347](/filings/0001288469-25-000008.md) | [29.9](/filings/0001288469-26-000011.md) | [(63.0)](/filings/0001288469-26-000011.md) | [7.0](/filings/0001288469-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mxl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.75bn | 13,700,399 |  | Added +295,662 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $886.4m | 6,923,428 |  | Reduced −2,239,787 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $553.8m | 4,325,471 |  | Reduced −742,126 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $489.4m | 3,822,902 |  | Added +167,826 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $285.0m | 2,225,731 |  | Added +148,300 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $262.5m | 2,050,213 |  | Reduced −453,234 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $261.7m | 2,044,128 |  | Added +1,606,954 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $238.3m | 1,861,351 |  | Added +1,835,443 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $235.2m | 2,164,757 |  | Added +1,867,244 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $211.4m | 1,650,824 |  | Reduced −3,611,846 |

## Recent filings

[All 1,739 filings](/companies/mxl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:13 ET | [10-Q](/filings/0001288469-26-000061.md) | Quarterly report, period 2026-09-30 | 0001288469-26-000061 |
| 2026-10-22 | 20:06 ET | [8-K](/filings/0001288469-26-000060.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001288469-26-000060 |
| 2026-07-23 | 20:08 ET | [10-Q](/filings/0001288469-26-000051.md) | Quarterly report, period 2026-06-30 | 0001288469-26-000051 |
| 2026-07-23 | 20:05 ET | [8-K](/filings/0001288469-26-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001288469-26-000050 |
| 2026-06-01 | 20:35 ET | [8-K](/filings/0001288469-26-000045.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001288469-26-000045 |
| 2026-05-21 | 20:40 ET | [8-K](/filings/0001288469-26-000035.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001288469-26-000035 |
| 2026-04-23 | 20:13 ET | [10-Q](/filings/0001288469-26-000029.md) | Quarterly report, period 2026-03-31 | 0001288469-26-000029 |
| 2026-04-23 | 20:07 ET | [8-K](/filings/0001288469-26-000027.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001288469-26-000027 |
| 2026-04-02 | 20:37 ET | [DEF 14A](/filings/0001288469-26-000021.md) | Proxy statement, period 2026-05-20 | 0001288469-26-000021 |
| 2026-02-17 | 13:35 ET | [8-K](/filings/0001288469-26-000017.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001288469-26-000017 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001288469-26-000011.md), filed Jan 29, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1288469
- Tickers: MXL
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.